Breast cancer cells treated with calcitriol decrease the expression of ZEB1, N-cadherin, vimentin, or integrins and increase the level of E-cadherin, suggesting that calcitriol reduces the EMT process [78]. This evidence concerns the gene CDH2 and breast cancer.